IL6 and metabolic dysfunction-associated steatotic liver disease: For example, 80 mg/day nanocurcumin supplementation in overweight non-alcoholic fatty liver disease patients for 3 months improved glucose indices and lipids and decreased TNF-α, hs-CRP, and IL-6 (Jazayeri-Tehrani et al., 2019 ▶).